32 related articles for article (PubMed ID: 20735399)
1. Contemporaneous Illustration of Megakaryopoiesis.
Gupta N; Dadu T; Mittal A; Handoo A
Indian J Hematol Blood Transfus; 2024 Apr; 40(2):364-365. PubMed ID: 38708159
[No Abstract] [Full Text] [Related]
2. Diagnostic and Prognostic Value of PACAP in Multiple Myeloma.
Tóth T; Alizadeh H; Polgár B; Csalódi R; Reglődi D; Tamás A
Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37445974
[TBL] [Abstract][Full Text] [Related]
3. Novel Therapies to Address Unmet Needs in ITP.
Mingot-Castellano ME; Bastida JM; Caballero-Navarro G; Entrena Ureña L; González-López TJ; González-Porras JR; Butta N; Canaro M; Jiménez-Bárcenas R; Gómez Del Castillo Solano MDC; Sánchez-González B; Pascual-Izquierdo C; On Behalf Of The Gepti
Pharmaceuticals (Basel); 2022 Jun; 15(7):. PubMed ID: 35890078
[TBL] [Abstract][Full Text] [Related]
4. Pituitary adenylate cyclase-activating polypeptide (PACAP) in zebrafish models of nephrotic syndrome.
Eneman B; Elmonem MA; van den Heuvel LP; Khodaparast L; Khodaparast L; van Geet C; Freson K; Levtchenko E
PLoS One; 2017; 12(7):e0182100. PubMed ID: 28759637
[TBL] [Abstract][Full Text] [Related]
5. Novel treatments for immune thrombocytopenia.
Shih A; Nazi I; Kelton JG; Arnold DM
Presse Med; 2014 Apr; 43(4 Pt 2):e87-95. PubMed ID: 24656294
[TBL] [Abstract][Full Text] [Related]
6. Emerging treatments for thrombocytopenia: increasing platelet production.
Peeters K; Stassen JM; Collen D; Van Geet C; Freson K
Drug Discov Today; 2008 Sep; 13(17-18):798-806. PubMed ID: 18602017
[TBL] [Abstract][Full Text] [Related]
7. PACAP and its receptor VPAC1 regulate megakaryocyte maturation: therapeutic implications.
Freson K; Peeters K; De Vos R; Wittevrongel C; Thys C; Hoylaerts MF; Vermylen J; Van Geet C
Blood; 2008 Feb; 111(4):1885-93. PubMed ID: 18000164
[TBL] [Abstract][Full Text] [Related]
8. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide enhance IL-10 production by murine macrophages: in vitro and in vivo studies.
Delgado M; Munoz-Elias EJ; Gomariz RP; Ganea D
J Immunol; 1999 Feb; 162(3):1707-16. PubMed ID: 9973433
[TBL] [Abstract][Full Text] [Related]
9. Vasoactive intestinal peptide/pituitary adenylate cyclase-activating peptide receptor subtypes in human tumors and their tissues of origin.
Reubi JC; Läderach U; Waser B; Gebbers JO; Robberecht P; Laissue JA
Cancer Res; 2000 Jun; 60(11):3105-12. PubMed ID: 10850463
[TBL] [Abstract][Full Text] [Related]
10. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide prevent inducible nitric oxide synthase transcription in macrophages by inhibiting NF-kappa B and IFN regulatory factor 1 activation.
Delgado M; Munoz-Elias EJ; Gomariz RP; Ganea D
J Immunol; 1999 Apr; 162(8):4685-96. PubMed ID: 10202009
[TBL] [Abstract][Full Text] [Related]
11. Thrombopoietic effect of VPAC1 inhibition during megakaryopoiesis.
Peeters K; Loyen S; Van Kerckhoven S; Stoffels K; Hoylaerts MF; Van Geet C; Freson K
Br J Haematol; 2010 Oct; 151(1):54-61. PubMed ID: 20735399
[TBL] [Abstract][Full Text] [Related]
12. From patient to mouse to therapy: role of the neuropeptide pacap in platelet function and formation.
Freson K
Verh K Acad Geneeskd Belg; 2010; 72(5-6):239-51. PubMed ID: 21409952
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
